tirzepatide delivered to your door If you've been struggling with cravings, stubborn weight, or finding a solution that actually fits lifestyle, it may be time explore a new option. 💉 Compound ✔️ No subscription 🚀 STOP THE GLP-1 SHORTAGE

PMID: 29033950

Clinical studies have shown that tirzepatide: Significantly reduces hemoglobin A1C levels compared to placebo Promotes weight loss in a dose-dependent manner May have potential benefits for non-alcoholic fatty liver disease (NAFLD) patients Tirzepatide is typically administered as follows: Once-weekly subcutaneous injection Available in various strengths (e.g., 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg) Dose is usually titrated over time to reach the target dose Common side effects may include: Nausea Diarrhea Decreased appetite Vomiting Constipation Abdominal pain Tirzepatide should be used with caution in patients with: History of pancreatitis Severe gastrointestinal disease Diabetic retinopathy Pregnancy: Tirzepatide should not be used during pregnancy unless the potential benefit justifies the potential risk to the fetus

PMID: 9859262

Di Mauro A, Tuccinardi D, Watanabe M, Del Toro R, Monte L, Giorgino R, et al